期刊文献+

外周血CD34^+造血干细胞加适量T细胞输注进行HLA半相合的异体移植 被引量:4

Allogeneic transplantation of purified haploidentical CD34^+ peripheral blood stem cells with suitable T cell reinfusion in treating Ph+ALL
暂未订购
导出
摘要 对1例Ph+染色体的急淋患儿进行母子间HLA半相合的异体外周血造血干细胞移植 ,为避免由于HLA不相合所产生的由T细胞介导的严重移植物抗宿主病(GVHD) ,采用了CD34+细胞正性分离去除淋巴细胞 ;同时为避免由于T细胞过度去除而引起宿主抗移植物反应(HVG)导致植入失败 ,在移植次日又加入部分T细胞 ,使病儿接受CD34 +细胞6×106/kg 和CD3 +细胞1.05×107/kg。结果 :随访1年来 ,红系、粒系和巨核系均恢复正常 ,临床上仅出现一过性的IIOaGVHD以及轻微的局限于口唇粘膜的cGVHD。STR位点DNA检验以及染色体检查 :移植后 +180天受体已从供体型嵌合体转为完全供体型 ,病儿获得植入成功。结果表明 ,常规剂量的CD34 +细胞移植加以适量CD3 +T细胞 ,可克服HLA部分不相配的难点 ,减轻GVHD ,同时也可避免由于过度的T细胞去除而出现的HVG。 One case of HLA haploidentical PBSCT from mother to the son was performed in the treatment of acute lymphoblastic leukemia with chromosom Ph+.To avoid severe 'graft versus host disease(GVHD)'following unmanipulated transplants,the positive selection method of CD34+cells with T cell depletion were used.Meanwhile,to avoid 'host versus graft(HVG)'following T cell_depleted transplants mediated by residual anti_donor cytotoxic T_lymphocyte(CTL) precursors that survived from the supralethal conditioning,suitable amount of T cells reinfusion by the addition of unmanipulated PBSC were performed on the next day.The patient received 6×106 CD34+ cells/kg and 1.05×107 CD34+ cells/kg totally. Thiskind of haploidentical transplantation was successful,with only moderate aGVHD and gentle cGVHD restricted only to lip.The conventional dosage of CD34+ cells plus suitable amount of CD3+ T cells transplantation can overcome the difficulty of GVHD or HVG in HLA partial mismatch,especially HLA haploidentical transplantation.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2002年第1期28-30,53,共4页 Journal of Clinical Pediatrics
关键词 母子HLA半相合PBSCT CD34^+细胞纯化移植 部份CD3^+细胞同时回输 异体造血干细胞移植 HLA haploidentical PBSCT from mother to the son purified CD34+ transplantation suitable amount of T cells reinfusion at the same time
  • 相关文献

参考文献6

  • 1Reisner Y. Aversa F, Lusting EB , et al.The role of me adose CD34 in haploidentical transplantation:Potential application to tolerance induction.Hematology 1999 American Society of Hematology Education Program Book,1999∶ 376-382.
  • 2Gluckman E.The EBMT Handbook," blood and marrow transplantation" .Parie:Roboot ante graphiguee.1998∶89-96.
  • 3Aversa F. Tabilio A,Terenzi A,et al.Successful engraftment of T-cells-depleted haploidentical " three_loci" incompatible transplantats in leukemia patients by addition of recombinant human granulocyte colony_stimu lating factor_mobilizaed peripheral blood progenitor cells to bone marrow inoculum. Blood, 1994 ,84(11)∶ 3948-3955.
  • 4Handgretinger R,Schumm M,Lang P,et al." Transplan tation of megadoses of purified haploidentical stemcells" .Ann NY Acad Sci,1999,827∶ 351-362.
  • 5Verdonck LF,Dekker AW,de Gast GC,et al. Allogeneic bone marrow transplantation with a fixed low number of T cell in the marrow graft.Blood,1994,83(10)∶ 3090-3096.
  • 6Dazzi F,Szydlo M,Cradock C,et al.Comparison of sing le_dose and escalating_dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia.Blood,2000,95∶ 67-69.

同被引文献37

  • 1Manton WI, Angle CR, Stanrek KL, et al. Release of lead from bone in pregnancy and lactation. Envion Res, 2003,92 ( 2 ) : 139-151.
  • 2Cohen M, Meisser A, Bisehof P. Metalloproteinases and human placental invasiveness.Placenta,2006,27(8):783-793
  • 3Aversa F,Terenzi A,Tabilio A,et al.Full haplotype mismatched hematopoietic stem-cell transplantation:A phase Ⅱ study in patients with acute leukemia at high risk of relapse. J Clin Oncol, 2005,23( 15): 3447-3454.
  • 4Handgretinger R,Schumm M,Ling P. et al. Transplantation of megadoses of purified haploidentical stem cells.Ann N Y Acad Sci. 1999.827:351-361.
  • 5van Rood JJ,Loberiza FR,Jr,Zhang MJ ,et al .Effect of tolerance to noninherited maternal antigens on the occurrence of GVHD after bone marrow transplantation from a parent or an HLA haploidentical sibling. Blood. 2002,99(5) :1572-1577.
  • 6Ruggeri L, Mancusi A, Burchielli E, et al. Natural killer cell alloreactivity in allogeneic hematopoetic transplantation. Curr Opin Oncol, 2007,19 (2) : 142-147.
  • 7Kalwak K,Moson I,Cwian J,et al .A prospective analysis of immune recovery in children following allogeneic transplantation of t-cell-depleted or non-T- cell-depleted hematopoietic cells from HLA-disparate family donors. Transplantat Proc.2003 ,35(4) : 1551-1555.
  • 8Lu DP, Dong L,Wu T, et al. Conditioning including antithymocyte globuling followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcome to HLA-identical sibling transplantation. Blood, 2006,107 ( 8 ) : 3065-3073.
  • 9Ji SQ,Chen HR, Yan HM,et al. Anti-CD25 monoclonal antibody(basilixinab) for prevention of GVHD after haploidentical bone mamow transplantation for hematological malignancies. Bone Marrow Transplant ,2005,36(4) :349-354.
  • 10Chen HR,Ji SQ,Wang HX,et al .Humanized anti-CD25 monoclonal antibody for prophylaxis of GVHD in haploidentical bone mamow transplantation without ex vivo T cell depletion. Exp Henmatol.2003,31 ( 11 ) : 1019-1025.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部